Content about Haemophilus influenzae

June 15, 2012
FDA approves MenHibrix

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

September 29, 2011
FDA declines to approve GSK vaccine

The Food and Drug Administration has declined to approve a vaccine developed by GlaxoSmithKline, the drug maker said.

October 10, 2010
Drug makers fight infectious diseases with 400 drugs in pipeline

Humanity has come a long way since the days when people thought sickness came from...

© 2013 Drug Store News. All Rights Reserved.